Interview with Dr. Ramalingam on First Line Advanced NSCLC and Maintenance Therapy

H. Jack West, MD, Founder, President and CEO

The ASCO meeting I'm at right now is so insanely busy during the days and nights that it's next to impossible to carve out the time to write posts during the meeting. While the talk show hosts just show re-runs while they're on vacation, we're at least going to put up some new content, even if it's from work previously done (and this is far from a vacation).

This podcast features Dr. Suresh Ramalingam, Director of the Thoracic Oncology Program from Winship Cancer Institute at Emory University in Atlanta. We discussed recent data that have led to changes in our current treatment standards for first line treatment of advanced NSCLC, as well as emerging evidence leading to debates about maintenance therapy after a fixed amount of initial chemotherapy. The video version includes synchronized figures. The audio is an mp3 file.

Ramalingam interview Adv NSCLC and Maintenance Aud

I'll add the figures and transcript very soon.

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation